SLC16A1 and nonpapillary renal cell carcinoma: Indeed, quantification of the relative expression levels of SLC16A1 mRNA in these different cell types confirmed a pattern where primary normal cells displayed low expression levels of SLC16A1, whereas both the primary ccRCC cells and the established cell lines expressed increased levels of this transporter (Figure 6c).